Elevra Consulting
Diagnosing Dx
How do we transform cutting-edge scientific discoveries into life-saving diagnostics? On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx. Learn to:🔹 Navigate industry challenges🔹 Understand emerging science🔹 Strategise for growth🔹 Gain future-focused insightEssential listening for everyone involved in bringing new sciences to life in the Dx and Omics industry, Subscribe now!
Glöm inte att besöka poddens webbplats och stötta skaparen: elevraconsulting.com
Skapare
Elevra Consulting
Kategori
Poddens webbplats
Senaste avsnittet
19 nov 2026
Var kan du lyssna?
Poddar i appen Replaio Radio Kommer snartPoddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar
Avsnitt
Workflow, Customers, and Course Corrections: Scott O’Brien on Scaling GenMark 29.09.2025 57:50
This week on Diagnosing Dx, I’m joined by Scott O’Brien, who helped lead GenMark from a small startup to a $1.8 billion acquisition by Roche. Scott shares how his transition from science to commercial strategy shaped GenMark’s journey, the critical role of customer experience in competing against industry giants, and what it really takes to scale a diagnostics company through both breakthroughs an...
Bench in a Box: Redefining PCR for Anywhere, Anytime Diagnostics - Josh Smith 23.09.2025 47:39
This week on Diagnosing Dx, I’m joined by Josh Smith, founder of Bench in a Box and scientist with a background in genetics and microbiology. Josh shares the breakthrough idea that inspired his platform, the journey to patent-pending status, and the realities of building a diagnostics startup in today’s economic climate. 🔥 What You’ll Learn: • The breakthrough behind Bench in a Box and its role i...
Going Global: Victoria Polyanskaya on Expanding Diagnostics Beyond the US 17.09.2025 44:53
This week on Diagnosing Dx, I’m joined by Victoria Polyanskaya, a healthcare leader with over 10 years of experience who is driving global expansion for LinusBio. We explore how diagnostics companies can successfully scale internationally, the opportunities in emerging markets, and the hard truths leaders need to hear when looking abroad. 🔥 What You’ll Learn: • Why exposomics is shaping the n...
Mission Meets Money: Dean Remy on Fundraising and the Future of Diagnostics 08.09.2025 57:49
This week on Diagnosing Dx , I’m joined by Dean Remy, a 35-year veteran of the life sciences industry, founder, and fundraising strategist. Dean shares his unique journey from diagnostics into technology and commercial leadership, and why fractional leadership is becoming a smart, cost-effective model for today’s startups. We dive into the evolving world of fundraising, the growing gap between inv...
Inside BioFire: Culture, Growth, and the Rocket Ship Ride - Rachel Jones 03.09.2025 1:06:21
This week on Diagnosing Dx, I’m joined by Rachel Jones,former Chief Commercial Officer at BioFire and now at VedaBio. Rachel shares her remarkable journey from bench scientist to helping rebrand Idaho Technology into BioFire, scaling its commercial team from just 12 people into a billion-dollar diagnostics powerhouse, and ultimately shaping one of the most iconic success stories in infectious dise...
From Hypothesis-Driven to Hypothesis-Free: The Future of Dx with Brad Murray 26.08.2025 44:35
This week on Diagnosing Dx, I’m joined by Bradley Murray, CEO and co-founder of Delve Bio. Bradley shares his journey from academic research, success as a biotech startup, investment into life sciences and onto entrepreneurship, andhow those experiences shaped his approach to building diagnostics that put patients first. We dive into why execution, not just vision is critical for survival in tod...
Truth-Seeking in Diagnostics: Lessons from Genomic Health to Mental Health - Tara Maddala 18.08.2025 48:52
This week on Diagnosing Dx, I’m joined by Tara Maddala,statistician, diagnostics veteran, and founder of Pandora Bio and Tiger Team Bio, whose career also spans Genomic Health and Grail. We explore how the truth-seeking culture at Genomic Healthshaped her approach to building and advising early-stage companies, why mental health diagnostics is still decades behind, and how AI is often misreprese...
From Science to Sales — The Hard Truths of Commercializing Diagnostics Today - Mark Oldroyd 12.08.2025 55:50
This week on Diagnosing Dx, I’m joined by Mark Oldroyd, a commercialisation strategist with over 30 years in healthcare, including leadership roles at Foundation Medicine, Tempus, and C2i Genomics. Mark has guided diagnostics and omics companies across the US, Europe, and Asia, helping them find the right path from breakthrough science to a sustainable business. 🔥What You’ll Learn: • Why movi...
AI, Virtual Staining & the Future of Pathology – James Kelley 05.08.2025 39:55
This week on Diagnosing Dx, I’m joined by James Kelley, Chief Medical Officer at Pictor Labs and a respected leader in lab medicine and diagnostics. We explore how AI is reshaping pathology, what makes virtual staining such a transformative innovation, and why data ownership and transparency are becoming urgent conversations for clinicians. From regulatory frameworks to AI education in healthcare,...
Building Assays, Battling COVID on the Frontline, and What’s Next in Dx – Vincent Funari 28.07.2025 47:34
This week on Diagnosing Dx, I’m joined by Vincent Funari, a genomics leader whose career spans from the Human Genome Project to pioneering liquid biopsy assays and driving innovation at NeoGenomics during its major growth years. We dive into how Vincent scaled R&D through M&A, led testing innovation during the COVID-19 crisis, and earned praise from the FDA for breakthrough assay develop...
LDT's safe for now, but for how long? What startups must know – Mort Minaee 25.07.2025 40:51
On this week’s episode of Diagnosing Dx, I’m joined by Mort Minaee, a seasoned regulatory strategist with over 35 years of experience at companies like Roche, Abbott, and Guardant Health. We unpack the FDA’s recent ruling, and reversal on LDTs (Laboratory Developed Tests) and what this moment of uncertainty means for diagnostics startups. Mort shares how to build a credible regulatory strategy tha...
How Pictor Is Scaling Proteomics for Faster, Smarter Testing – Janine McMurdie 14.07.2025 49:15
This week on Diagnosing Dx, I’m joined by Janine McMurdie, Chief Commercial Officer at Pictor, a company unlocking the next wave of innovation in diagnostics through proteomics. With a career spanning industry giants like Amgen and IonTorrent, Janine shares what it takes to lead in a fast-evolving space - where scalability, speed, and strategy matter more than ever. We dive into how Pictor’s flexi...
Developing Biomarker strategies and the future of Prognostics - Sam Agus 08.07.2025 56:06
This week on Diagnosing Dx, I’m joined by Dr. Sam Agus, a neurologist and diagnostics innovator with over 20 years of experience in clinical trials, biomarker development, and early-stage ventures. In this candid conversation, Sam shares the hard truths about why diagnostics companies struggle for funding, why prognostics are quietly becoming the next frontier, and how early partnerships - espec...
MDx innovation and culture and the future of diagnostics R&D – Kim Langone 01.07.2025 56:17
This week on Diagnosing Dx, we’re joined by Kim Langone, SVP of R&D at Fellow Health, and former 10th employee at Genomic Health, where for 19 years, she played a pivotal role in developing Oncotype DX, a landmark diagnostic test for breast cancer. With 24 years of experience in molecular diagnostics, Kimshares what it takes to build breakthrough science in a startup, scale it, and navigate...
Regulatory strategy for startups in Dx and mistakes to avoid – Heinz Steneberg 25.06.2025 51:57
This week on Diagnosing Dx, we’re joined by Heinz Steneberg, President and CEO of MDSS, for a deep dive into the role of Regulatory Strategy in Diagnostics and MedTech startups. From early-stage planning to FDA engagement, we cover the decisions that make or break go-to-market timelines - and how emerging models are shaping the regulatory future. 🔥 What You’ll Learn: • How to use FDA pre-submissi...
Liknande poddar
Replaio är ingen poddutgivare; programnamn, omslag och ljud tillhör sina upphovspersoner och distribueras via offentliga RSS-flöden